NDC 58160-818

Hiberix

Haemophilus B Conjugate Vaccine (tetanus Toxoid Conjugate)

Hiberix is a Kit in the Vaccine category. It is labeled and distributed by Glaxosmithkline Biologicals Sa. The primary component is .

Product ID58160-818_18462999-a98f-4be2-baef-6ed771434bfe
NDC58160-818
Product TypeVaccine
Proprietary NameHiberix
Generic NameHaemophilus B Conjugate Vaccine (tetanus Toxoid Conjugate)
Dosage FormKit
Marketing Start Date2015-12-21
Marketing CategoryBLA / BLA
Application NumberBLA125347
Labeler NameGlaxoSmithKline Biologicals SA
Active Ingredient Strength0
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 58160-818-11

1 KIT in 1 CARTON (58160-818-11) * 10 VIAL in 1 CARTON (58160-816-05) > .5 mL in 1 VIAL (58160-816-01) * 10 VIAL in 1 PACKAGE (58160-817-05) > .85 mL in 1 VIAL (58160-817-01)
Marketing Start Date2015-12-21
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 58160-818-11 [58160081811]

Hiberix KIT
Marketing CategoryBLA
Application NumberBLA125347
Product TypeVACCINE
Billing UnitEA
Marketing Start Date2015-12-21

Drug Details


Trademark Results [Hiberix]

Mark Image

Registration | Serial
Company
Trademark
Application Date
HIBERIX
HIBERIX
86916992 not registered Dead/Abandoned
GlaxoSmithKline Biologicals S.A.
2016-02-23
HIBERIX
HIBERIX
78188524 2987155 Live/Registered
GlaxoSmithKline Biologicals S.A.
2002-11-25

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.